Circulating osteopontin: a dual marker of bone destruction and angiogenesis in patients with multiple myeloma
<p>Abstract</p> <p>The matrix protein osteopontin has been shown to be a marker of osteoclastic activity in multiple myeloma patients, as well as a regulator of angiogenesis. We measured serum levels of osteopontin in 50 untreated multiple myeloma patients (in 25, also after treatm...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-05-01
|
Series: | Journal of Hematology & Oncology |
Online Access: | http://www.jhoonline.org/content/4/1/22 |